400 related articles for article (PubMed ID: 19615558)
1. Emerging topics in pediatric bone and mineral disorders 2008.
McKay CP; Portale A
Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
Bielesz B
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
4. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
5. Novel regulators of phosphate homeostasis and bone metabolism.
Jüppner H
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
Damasiewicz MJ; Toussaint ND; Polkinghorne KR
Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
[TBL] [Abstract][Full Text] [Related]
7. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
[TBL] [Abstract][Full Text] [Related]
8. Correlation among hyperphosphatemia, type II sodium phosphate transporter activity, and vitamin D metabolism in Fgf-23 null mice.
Sitara D
Ann N Y Acad Sci; 2007 Nov; 1116():485-93. PubMed ID: 17646263
[TBL] [Abstract][Full Text] [Related]
9. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23 and its receptors.
Yu X; White KE
Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
Cozzolino M; Ciceri P; Volpi EM; Olivi L; Messa PG
Blood Purif; 2009; 27(4):338-44. PubMed ID: 19295196
[TBL] [Abstract][Full Text] [Related]
12. Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing.
Chattopadhyay N; Brown EM
Mol Genet Metab; 2006 Nov; 89(3):189-202. PubMed ID: 16919492
[TBL] [Abstract][Full Text] [Related]
13. The role of bone in phosphate metabolism.
Fukumoto S
Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
Williams ME
Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
[TBL] [Abstract][Full Text] [Related]
15. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
Yamamoto T; Imanishi Y; Kinoshita E; Nakagomi Y; Shimizu N; Miyauchi A; Satomura K; Koshiyama H; Inaba M; Nishizawa Y; Jüppner H; Ozono K
J Bone Miner Metab; 2005; 23(3):231-7. PubMed ID: 15838626
[TBL] [Abstract][Full Text] [Related]
16. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
18. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
Michigami T
Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
[TBL] [Abstract][Full Text] [Related]
19. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
Hesse M; Fröhlich LF; Zeitz U; Lanske B; Erben RG
Matrix Biol; 2007 Mar; 26(2):75-84. PubMed ID: 17123805
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and bone consequences of cyclic nutritional changes in the calcium, phosphate and vitamin D status in the rat: an in vivo depletion-repletion-redepletion study.
Mailhot G; Petit JL; Dion N; Deschênes C; Ste-Marie LG; Gascon-Barré M
Bone; 2007 Sep; 41(3):422-36. PubMed ID: 17617234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
